Professor Laurent Servais has recently been appointed Professor of Paediatric Neuromuscular Diseases at the MDUK Oxford Neuromuscular Centre. Not only does Professor Servais have great general experience of neuromuscular disease, he is also in charge of the natural history study for x-linked myotubular myopathy and dynamin 2.
The Oxford Neuromuscular Centre is a partnership between Muscular Dystrophy UK (MDUK) and the University of Oxford, which aims to drive research into potential treatments from the lab into the clinic. The aim of the centre will be to boost capacity for clinical trials while working alongside the major centres in Newcastle and London.
Professor Servais will join the MDUK Oxford Neuromuscular Centre with a wealth of experience within the neuromuscular field, having overseen numerous clinical trials to test treatments for duchenne muscular dystrophy and spinal muscular atrophy (SMA). He is also the leader of the newborn screening program for SMA in southern Belgium.
Currently Head of the Institute I-Motion, in Paris and Head of the Neuromuscular Centre in Liège, Belgium, Professor Servais is also a Professor of Child Neurology at Liège University. He will cease his activity in Paris, but will keep an affiliation in his hometown hospital and university as an invited Professor.
Professor Servais will start his tenure with the MDUK Oxford Neuromuscular Centre in September 2019 and will relocate to Oxford from Belgium.